117015 ⎘
Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Aspartic endopeptidases (3.4.23) Memapsin 2 (3.4.23.46), i.e. beta-secretase 1 or BACE
Animal Model With Rapid Onset Of Alzheimer's Amyloid Beta Plaque Pathology
#2aPKC INHIBITORS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE OR DISORDER
#3GENE THERAPY FOR NEURODEGENERATIVE DISORDERS USING POLYNUCLEOTIDE SILENCING AND REPLACEMENT
#4APKC inhibitors and methods of treating a neurodegenerative disease or disorder
#5METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES
#6Antibodies against BACE1 and use thereof for neural disease immunotherapy
#7GENE THERAPY FOR ALZHEIMER`S DISEASE
#8aPKC INHIBITORS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE OR DISORDER
#9Recombinant protein-based method for the delivery of silencer RNA to target the brain
#10Method of manufacturing membrane protein and utilization thereof
#11Recombinant protein-based method for the delivery of silencer RNA to target the brain
#12Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use
#13METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES
#14BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND METHODS OF USE
#15Antibodies against BACE1 and use thereof for neural disease immunotherapy
#16OLIGONUCLEOTIDE COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#17RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)
#18RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#19Constructs for homogenously processed preparations of beta site APP-cleaving enzyme